SCHEMBL10114593

SCHEMBL10114593

Cc1csc(NC(=O)c2ccc(O)c(Cl)c2)n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.69
GCK P35557 4/20 0.67
GRM5 P41594 1/20 0.67
NPC1 O15118 8/20 0.63
RAB9A P51151 8/20 0.63
ALDH1A1 P00352 3/20 0.58
KMT2A Q03164 3/20 0.58
HPGD P15428 3/20 0.58
MEN1 O00255 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
LMNA P02545 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
GAA P10253 2/20 0.57
HSD17B10 Q99714 2/20 0.56
KDM4E B2RXH2 1/20 0.56
TP53 P04637 1/20 0.56
HTT P42858 1/20 0.56
RCE1 Q9Y256 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426988 0.86 GCK (0.69) MAPTGCKGRM5NPC1RAB9A
SCHEMBL13951760 0.82 HSD17B10 (0.52) MAPTGCKGRM5NPC1RAB9A
SCHEMBL4757228 0.80 HSD17B10 (0.47) MAPTGCKGRM5NPC1RAB9A
SCHEMBL14886015 0.79 GCK (0.75) MAPTGCKGRM5NPC1RAB9A
SCHEMBL16257641 0.78 HSD17B10 (0.48) MAPTGCKGRM5NPC1RAB9A
SCHEMBL10114414 0.77 GRM5 (0.68) MAPTGCKGRM5NPC1RAB9A
SCHEMBL8560618 0.77 GCK (0.79) MAPTGCKGRM5NPC1RAB9A
SCHEMBL1270190 0.76 NPC1 (1.00) MAPTGCKGRM5NPC1RAB9A
SCHEMBL28781721 0.76 NPC1 (0.71) MAPTGCKGRM5NPC1RAB9A
SCHEMBL7343145 0.75 MAPT (0.68) MAPTGCKGRM5NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MAPT 4288/4885GCK 1360/4885GRM5 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.